Lyn Finelli

Merck & Co., Inc., Rahway, NJ, USA (United States) — United States

Medicine · Health Sciences

71h-index31.6kcitations241works2.62yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Influenza Virus Research Studies(124), Respiratory viral infections research(120), Pneumonia and Respiratory Infections(50), COVID-19 epidemiological studies(36), Vaccine Coverage and Hesitancy(17)

Publications241 total

Caregiver psychological burden of RSV Hospitalization of children 2 years of age and under
PLoS ONE·2025Open Access
Evaluation of a monoclonal antibody against respiratory syncytial virus, clesrovimab, in infants and children: Comprehensive rationale and study design for the late-stage clinical trials
Contemporary Clinical Trials·2025· 10 cited
Respiratory Syncytial Virus Risk Assessment in Adults: Implications for Vaccine Recommendations Beyond Age
Open Forum Infectious Diseases·2025Open Access
Respiratory Syncytial Virus Incidence in Young Children in the United States: Impact of Methodologies and Patient Characteristics
Influenza and Other Respiratory Viruses·2025· 1 citedOpen Access
Author response for "Respiratory Syncytial Virus Incidence in Young Children in the United States: Impact of Methodologies and Patient Characteristics"
2025
Impact of Age and Comorbid Conditions on Incidence Rates of COVID‐19‐Associated Hospitalizations, 2020–2021
Influenza and Other Respiratory Viruses·2024Open Access
Outcomes Associated with Healthcare-Associated Respiratory Syncytial Virus in Children’s Hospitals
Journal of the Pediatric Infectious Diseases Society·2024· 3 citedOpen Access
Residency in Long-Term Care Facilities: An Important Risk Factor for Respiratory Syncytial Virus Hospitalization
The Journal of Infectious Diseases·2024· 9 citedOpen Access
Psychometric evaluation of the respiratory syncytial virus infection, intensity and impact questionnaire (RSV-iiiQ) in adults
Health and Quality of Life Outcomes·2024Open Access
2609. Comprehensive cost assessment among families with children younger than 2 years-of-age hospitalized with RSV infection
Open Forum Infectious Diseases·2023Open Access
Association of SARS-CoV-2 status and antibiotic-resistant bacteria with inadequate empiric therapy in hospitalized patients: a US multicenter cohort evaluation (July 2019 - October 2021)
BMC Infectious Diseases·2023· 5 citedOpen Access
Healthcare-Associated Respiratory Syncytial Virus in Children’s Hospitals
Journal of the Pediatric Infectious Diseases Society·2023· 7 citedOpen Access
Assessing the patient experience of respiratory syncytial virus infection: development of a patient-reported outcome measure
Health and Quality of Life Outcomes·2023· 5 citedOpen Access
Morbidity and mortality of hospitalised patients with candidemia during the various severe acute respiratory syndrome coronavirus 2 pandemic waves: A multicentre evaluation of 248 <scp>US</scp> hospitals
Mycoses·2023· 10 citedOpen Access
Association of SARS-CoV-2 status and antimicrobial-resistant bacteria with inadequate empiric therapy in hospitalized patients: a US multicenter cohort evaluation (July 2019 - October 2021)
Research Square (Research Square)·2023Open Access
Real-Time Monitoring of Infectious Disease Outbreaks with a Combination of Google Trends Search Results and the Moving Epidemic Method: A Respiratory Syncytial Virus Case Study
Tropical Medicine and Infectious Disease·2023· 16 citedOpen Access
Clinical impact of healthcare-associated respiratory syncytial virus in hospitalized adults
Infection Control and Hospital Epidemiology·2022· 20 citedOpen Access
Epidemiology and outcomes of culture-positive bloodstream pathogens prior to and during the SARS-CoV-2 pandemic: a multicenter evaluation
BMC Infectious Diseases·2022· 26 citedOpen Access
A Multicenter Comparison of Prevalence and Predictors of Antimicrobial Resistance in Hospitalized Patients Before and During the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic
Open Forum Infectious Diseases·2022· 27 citedOpen Access
The clinical impact of multiple prevention strategies for respiratory syncytial virus infections in infants and high-risk toddlers in the United States
Vaccine·2022· 7 citedOpen Access
page 1 of 13Next →

Frequent Co-authors

Carrie Reed(15), David L. Swerdlow(10), Alicia M. Fry(8), Marc Lipsitch(7), Seema Jain(6), Anna M. Bramley(6), Anthony E. Fiore(6), Matthew Biggerstaff(6), Stephen Lindstrom(5), Miriam J. Alter(5), Daniel B. Jernigan(5), Timothy M. Uyeki(5), Laurie Kamimoto(5), Joseph Bresee(5), Kathryn M. Edwards(4), Carolyn B. Bridges(4), Sonja J. Olsen(4), Beth P. Bell(4), Sandra S. Chaves(4), Jan Baumbach(4)